Minute-to-minute fluctuations in human brain activity, linked to changing levels of dopamine, impact whether we make risky decisions, finds a new study. The findings, published in the Proceedings of the National Academy of Sciences (PNAS), could explain why humans are inconsistent and sometimes irrational.
"Experts have long struggled to explain why people are so erratic, making one decision one day and the opposite decision another day. We know that the brain is constantly active, even when we aren't doing anything, so we wondered if this background activity affects our decision-making," said the study's co-lead author.
"It appears that our inconsistent behavior is partly explained by what our brain is doing when we are doing nothing."
The researchers focused on people in a state of rest (awake but not doing anything). At rest, the human brain remains active, with strong fluctuations in activity that remain unexplained.
For the study, 43 people completed a gambling task while in an MRI scanner. They were asked to choose between a safe option (gaining a small amount of money) and a risky option (gambling to try to get a larger amount of money). If they chose the risky option and lost, they would receive nothing.
The researchers monitored brain activity in the dopaminergic midbrain, the area of the human brain containing most of the dopamine neurons. Dopamine is a neurotransmitter known to play a role in risky decision-making. Whenever the activity in that brain area was either very high or very low, the study participants were asked to make a decision between a risky and a safe option.
The researchers found that when this brain area was in a state of low activity before participants were presented with their options, they were more likely to choose the risky option than when their brains were in a state of high activity (while still lying idle in the scanner).
Assessing the impact of these brain fluctuations, the researchers say the effect size is comparable to other known factors affecting risk-taking behavior, such as drugs that influence the neurotransmitter dopamine that are routinely taken by people with Parkinson's disease. The effect is also similar to ageing; being young is associated with greater risk-taking compared to being elderly.
"Our brains may have evolved to have spontaneous fluctuations in a key brain area for decision making because it makes us more unpredictable and better able to cope with a changing world," explained senior author.
The researchers aim to continue their research to find out if variations in background brain activity may have other impacts, and whether they could be related to other medical conditions in case the findings could eventually inform treatment approaches, such as for pathological gambling.
"Our findings underscore the importance of taking time when making important decisions, as you might make a different decision if you just wait a few minutes," said co-lead author.
https://www.pnas.org/content/early/2019/08/20/1900872116
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fendogenous-fluctuations&filter=22
Spontaneous brain fluctuations influence risk-taking
- 1,110 views
- Added
Edited
Latest News
Protein that helps COVID-19…
By newseditor
Posted 26 Jul
Spinal Muscular Atrophy (SM…
By newseditor
Posted 26 Jul
Link between bowel movement…
By newseditor
Posted 26 Jul
Inhibition of IL-11 signall…
By newseditor
Posted 25 Jul
Brain changes linked to obe…
By newseditor
Posted 25 Jul
Other Top Stories
Why high blood glucose levels in some flu patients experience sever…
Read more
Bile metabolite of gut microbes boosts immune cells
Read more
Modeling social distancing strategies for curbing the COVID-19 pand…
Read more
How lung cells involved in COVID-19 infection exploit our immune de…
Read more
Why some children get milder RSV infections than others
Read more
Protocols
A systems biology approach…
By newseditor
Posted 24 Jul
quantms: a cloud-based pipe…
By newseditor
Posted 22 Jul
Emerging tools and best pra…
By newseditor
Posted 19 Jul
Directly selecting cell-typ…
By newseditor
Posted 17 Jul
PUFFFIN: an ultra-bright, c…
By newseditor
Posted 16 Jul
Publications
Hepatocyte-intrinsic SMN de…
By newseditor
Posted 26 Jul
Aberrant bowel movement fre…
By newseditor
Posted 26 Jul
A pseudoautosomal glycosyla…
By newseditor
Posted 26 Jul
Microglia protect against a…
By newseditor
Posted 26 Jul
Rigor and reproducibility i…
By newseditor
Posted 26 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar